SCHEMBL5099324

SCHEMBL5099324

CC(=O)CCCC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20346867 0.94 ALDH1A1 (0.59)
SCHEMBL13398683 0.92 ALDH1A1 (0.64)
SCHEMBL13398970 0.92 ALDH1A1 (0.64)
SCHEMBL11989150 0.92 ALDH1A1 (0.64)
SCHEMBL13398965 0.92 ALDH1A1 (0.64)
SCHEMBL15281652 0.92 ALDH1A1 (0.64)
SCHEMBL29026075 0.85 ALDH1A1 (0.48)
SCHEMBL180666 0.84
SCHEMBL988309 0.84
SCHEMBL160547 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117534631-B Phenylthiazole amine PI4KIII beta inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-04-05 CN claimed
CN-117534631-A Phenylthiazole amine PI4KIII beta inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-02-09 CN claimed
CN-117534631-B Phenylthiazole amine PI4KIII beta inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-04-05 CN disclosed
CN-117534631-A Phenylthiazole amine PI4KIII beta inhibitor, preparation method, pharmaceutical composition and application thereof 南京市鸿舜医药科技有限公司 2024-02-09 CN disclosed
US-20230285561-A1 Targeting Microbubbles CALIFORNIA INSTITUTE OF TECHNOLOGY 2023-09-14 US disclosed
US-11642410-B2 Targeting microbubbles CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2023-05-09 US disclosed
US-20180217498-A1 PHOTOACTIVABLE NITROGEN BASES BASF SE (DE) 2018-08-02 US disclosed
US-9921477-B2 Photoactivable nitrogen bases BASE SE (DE) 2018-03-20 US disclosed
US-20160367669-A1 TARGETING MICROBUBBLES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-12-22 US disclosed
US-8735609-B2 Bryostatin analogues, synthetic methods and uses THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2014-05-27 US disclosed
US-20130123518-A1 Bryostatin Analogues, Synthetic Methods and Uses THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2013-05-16 US disclosed
CN-1350458-A Protease inhibitors SMITHKLINE BEECHAM CORP (US) 2002-05-22 CN disclosed
EP-1158986-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2002-03-27 EP disclosed
WO-2001095911-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-20 WO disclosed
EP-1158986-A1 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2001-12-05 EP disclosed
WO-2000038687-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2000-07-06 WO disclosed
US-5939428-A ANTITUMOR AGENTS AND ANTIGROWTH AGENTS FOR CELLS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 1999-08-17 US disclosed
US-5354864-A Antitumor agents SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1994-10-11 US disclosed
WO-1993023049-A1 3-(9-ACRIDINYLAMINO)-5-HYDROXYMETHYLANILINE DERIVATIVES AS ANTICANCER AGENTS SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1993-11-25 WO disclosed
US-4127612-A 19-Hydroxy PGE1 carbinol analogues MILES LABORATORIES, INC. (US) 1978-11-28 US disclosed